<SEC-DOCUMENT>0000950103-21-017734.txt : 20211112
<SEC-HEADER>0000950103-21-017734.hdr.sgml : 20211112
<ACCEPTANCE-DATETIME>20211112092757
ACCESSION NUMBER:		0000950103-21-017734
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20211112
FILED AS OF DATE:		20211112
DATE AS OF CHANGE:		20211112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AC Immune SA
		CENTRAL INDEX KEY:			0001651625
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37891
		FILM NUMBER:		211400457

	BUSINESS ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
		BUSINESS PHONE:		41 21 345 91 21

	MAIL ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>dp161675_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 3pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR<BR>
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of November, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission file number: 001-37891</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AC IMMUNE SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EPFL Innovation Park<BR>
Building B<BR>
1015 Lausanne, Switzerland</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;No <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 3pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>AC IMMUNE SA</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Andrea Pfeifer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Andrea Pfeifer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Joerg Hornstein</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Joerg Hornstein</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Date: November 12, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-right: 6pt; vertical-align: top; width: 8%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.5pt solid"><B>Exhibit
Number</B></P></TD>
    <TD STYLE="padding-right: 6pt; vertical-align: bottom; width: 92%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.5pt solid"><B>Description</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding-right: 6pt"><FONT STYLE="font-size: 10pt">Press Release dated November 12, 2021</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dp161675_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 40%; font-size: 12pt; text-align: left; font-weight: bold"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 48.4pt; width: 155.2pt"></TD>
    <TD STYLE="vertical-align: top; width: 30%; font-size: 12pt; text-align: left; font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 30%">
    <P STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.65pt 0pt 0; text-align: right"><FONT STYLE="text-transform: uppercase">Press
    Release </FONT></P>
    <P STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 5.65pt 0pt 0; text-align: right">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>AC Immune Announces Interim Phase 1b/2a Data
Showing that its ACI-35.030 <BR>
Anti-pTau Alzheimer&rsquo;s Vaccine Generates a Potent Immune Response</B></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><I>Observed strong induction of antibodies
specific for pathological forms of Tau with ACI-35.030 treatment</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><I>New data presented at 14<SUP>th</SUP>
CTAD conference support ACI-35.030&rsquo;s advancement into late-stage development </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Lausanne, Switzerland, November 12, 2021</B>
&ndash; AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative
diseases, today presented new interim Phase 1b/2a data on ACI-35.030, a first-in-class anti-phosphorylated-Tau (pTau) vaccine candidate
being developed in partnership with Janssen Pharmaceuticals, Inc., at the 14<SUP>th</SUP> Clinical Trials on Alzheimer's Disease (CTAD)
conference, which is being held in Boston, Massachusetts from November 9-12, 2021.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">ACI-35.030 is the first AD vaccine candidate designed
to generate antibodies targeting pathological pTau in the brain. At CTAD, AC Immune&rsquo;s Chief Medical Officer Johannes Streffer gave
an on-demand oral presentation featuring data from an ongoing, <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">placebo-controlled
</FONT>Phase 1b/2a trial evaluating ACI-35.030 in participants with early Alzheimer&rsquo;s disease (AD). Results from the trial show
that ACI-35.030 treatment led to the strong induction of antibodies specific for pathological forms of Tau such as pTau and its aggregated
form, enriched paired helical filaments (ePHF).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Additional key findings from the CTAD presentation
include:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #C00000">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Anti-pTau IgG titers increased by two orders of magnitude from baseline
already two weeks after the first injection of the mid-dose of ACI-35.030 </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #C00000">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Anti-ePHF IgG titers increased by one order of magnitude from baseline as
early as two weeks after the second injection at week 8 of the mid-dose of ACI-35.030</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #C00000">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The anti-ePHF IgG response was boosted following additional doses at weeks
8 and 24</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #C00000">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The ACI-35.030-induced immune response was lasting over an initial period
of 26-weeks and showed class-switching from IgM to IgG </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #C00000">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Interim safety data further support ACI-35.030&rsquo;s favorable safety
and tolerability profile, with no clinically relevant safety concerns observed to date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As previously announced, the ongoing Phase 1b/2a study has been expanded
to include a total of 24 AD participants in the mid-dose sub-cohort. This expansion was designed to support the advancement of ACI-35.030
into late-stage development.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Prof. Andrea Pfeifer, CEO of AC Immune SA, commented:
&ldquo;</B>To see such a strong and lasting immune response against a self-protein in an elderly population is both an exceptional finding
and an important step towards shifting the AD treatment paradigm towards earlier treatment and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: right; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;/&nbsp;3</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">prevention. Pathological pTau is present in the
CSF as a precursor many years before Tau accumulation is detectable via imaging techniques. By developing ACI-35.030 while leveraging
cutting edge Tau diagnostics, we aim to deliver on the significant promise this anti-pTau vaccine has shown as a potential early intervention
for AD. We look forward to continuing our collaboration with Janssen Pharmaceuticals, Inc. and to reporting additional immunogenicity
data from the Phase 1b/2a trial&rsquo;s high-dose group.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Prof. Philip Scheltens, Professor of Neurology
at Amsterdam UMC Alzheimer Center and Principal Investigator of the Phase 1b/2a study, commented: </B>&ldquo; These promising results
provide important preliminary data, and these findings may aid in dose selection for later stage investigation. This information will
be invaluable as we work to further ACI-35.030&rsquo;s clinical development and ultimately fulfill the hopes of clinicians and patients
for a therapy that could delay, or even prevent, the onset of AD.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>About the SupraAntigen<SUP>&reg;</SUP> platform</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">AC Immune&rsquo;s clinically validated SupraAntigen<SUP>&reg;
</SUP>platform uses proprietary liposomes to rapidly generate novel vaccines (SupraAntigen<SUP>&reg;</SUP>-V) for active immunization
as well as best-in-class monoclonal antibodies (SupraAntigen<SUP>&reg;</SUP>-A) for passive immunization against key neurodegenerative
disease targets. Antibodies generated by the platform are highly specific for the pathological conformations of misfolded proteins and
have shown strong safety. The SupraAntigen<SUP>&reg;</SUP> platform has successfully generated two vaccines and two antibody candidates
that have been validated in clinical studies and has led to multiple global partnerships with world-leading pharmaceutical companies.
In addition to targeting Amyloid-beta and Tau, AC Immune has generated conformation-specific antibodies against emerging neurodegenerative
disease targets including alpha-synuclein, TDP-43 and the NLRP3 inflammasome pathway.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>About the Phase 1b/2a pTau AD Vaccine Trial</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Phase 1b/2a study is a randomized, multicenter,
double-blind, placebo-controlled clinical study with a primary objective to assess the safety, tolerability and immunogenicity of different
dosages of ACI-35.030 and JACI-35.054 in participants with early AD. Secondary objectives will assess additional immunogenicity parameters,
while exploratory endpoints will include notable biomarkers of progression of AD as well as clinical assessments. This Phase 1b/2a study
evaluating ACI-35.030 and JACI-35.054 was initiated in Q3 2019 and is currently ongoing.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>About AC Immune SA
</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">AC Immune SA&nbsp;is clinical-stage biopharmaceutical
company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer&rsquo;s disease,
Parkinson&rsquo;s disease, and NeuroOrphan indications driven by misfolded proteins. The Company&rsquo;s two clinically validated technology
platforms, SupraAntigen<SUP>&reg;</SUP>&nbsp;and Morphomer<SUP>&reg;</SUP>, fuel its broad and diversified pipeline of first- and best-in-class
assets, which currently features ten therapeutic and three diagnostic candidates, six of which are currently in clinical trials.&nbsp;AC
Immune&nbsp;has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including&nbsp;Genentech,
a member of the Roche Group, Eli Lilly and Company, and&nbsp;Janssen</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: right; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;/&nbsp;3</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Pharmaceuticals, Inc., resulting in substantial
non-dilutive funding to advance its proprietary programs and &gt;$3&nbsp;billion&nbsp;in potential milestone payments.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">SupraAntigen<SUP>&reg;</SUP>&nbsp;is a registered
trademark of&nbsp;AC Immune SA&nbsp;in the following territories: AU, EU, CH, GB, JP and RU. Morphomer<SUP>&reg;</SUP>&nbsp;is a registered
trademark of&nbsp;AC Immune SA&nbsp;in CN, CH, GB, JP, and NO.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>For further information, please contact:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><B>Media Relations</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Saoyuth Nidh&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">AC Immune</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Phone: +41 21 345 91 34&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Email: <FONT STYLE="color: blue"><U>saoyuth.nidh@acimmune.com</U></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P></TD>
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><B>Investor Relations</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Yves Kremer, Ph.D.&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">AC Immune</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Phone: +41 21 345 91 90&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Email: <FONT STYLE="color: blue"><U>yves.kremer@acimmune.com</U></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><B>U.S. Media</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Shani Lewis&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">LaVoieHealthScience</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Phone: +1 609 516 5761&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Email: <FONT STYLE="color: blue"><U>slewis@lavoiehealthscience.com</U></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><B>U.S. Investors</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Corey Davis, Ph.D.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">LifeSci Advisors&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Phone: +1 212 915 2577</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">Email: <FONT STYLE="color: blue"><U>cdavis@lifesciadvisors.com</U></FONT>&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Forward looking statements</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This press release contains statements that constitute
&ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Forward-looking statements are statements other than historical fact and may include statements that address future
operating, financial or business performance or AC Immune&rsquo;s strategies or expectations. In some cases, you can identify these statements
by forward-looking words such as &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expects,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;projects,&rdquo;
&ldquo;potential,&rdquo; &ldquo;outlook&rdquo; or &ldquo;continue,&rdquo; and other comparable terminology. Forward-looking statements
are based on management&rsquo;s current expectations and beliefs and involve significant risks and uncertainties that could cause actual
results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties
include those described under the captions &ldquo;Item 3. Key Information &ndash; Risk Factors&rdquo; and &ldquo;Item 5. Operating and
Financial Review and Prospects&rdquo; in AC Immune&rsquo;s Annual Report on Form 20-F and other filings with the Securities and Exchange
Commission. These include: the impact of Covid-19 on our business, suppliers, patients and employees and any other impact of Covid-19.
Forward-looking statements speak only as of the date they are made, and AC Immune does not undertake any obligation to update them in
light of new information, future developments or otherwise, except as may be required under applicable law. All forward-looking statements
are qualified in their entirety by this cautionary statement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: right; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;/&nbsp;3</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +E"3H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXD6O5$U%%%48A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "E5F1@RDJP.00<$&DHH ]I\!^,!KUI]AO7']HPKU/\
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MI\+5]K2C(]2E+F@F%%%%=!H%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '7?#G6#IGBB.!VQ!>CR6';=_"?SX
M_P"!5[=7S+'(\,J21L5=&#*P[$=*^C=)OUU32+2^3 $\2N0.Q(Y'X'(KKPTM
M'$^6S_#\LXUEUT?R_P" 7:***Z3YX**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^Y/^_+?X5T5O/'=6\<\+!HI%#HP[@C(H DHHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9E[<^8WEH?
MD'7W-6+VX\M-BGYV_05F5\_F^-_YAX/U_P O\S:G#JPJ6"$SRA1T[GT%1 $D
M <DUL6T @B _B/+&O/R[!_6:NOPK?_(N<N5$JJ$4*HP!TI:**^O225D<P444
M4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ/^
MJ0_[59U:6H_ZE/\ >K-KY+-_]Z?HOR.FG\(57O+M+.V:5^W"CU-3LP52S$
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M#^(KC*Z[X?:1]OUS[9(N8;,;^>[G[OY<G\!2 ]84DJ"1@D<CTI:**0PHHHH
M**** "BBB@ HHHH *\1\6?\ (UZE_P!=C_(5[=7B/BS_ )&O4O\ KL?Y"F@,
M:O4/AE_R!;S_ *^/_917E]>H?#+_ ) MY_U\?^RBAB.WHHHI#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[3O^OJ+_ -"%4:NZ0@DUJP0YPUQ&#C_>%"W(J_!+T?Y,^CZ***]0_. HHHH
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MR//Y&MGPUH:Z!I"6A97E+%Y74<,3_P#6P*V** "BBB@ HHHH **** "BBB@
MHHHH *\1\6?\C7J7_78_R%>W5XCXL_Y&O4O^NQ_D*: QJ]0^&7_(%O/^OC_V
M45Y?7J'PR_Y MY_U\?\ LHH8CMZ***0PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;511P!4M%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>(^+/^1KU+_KL?Y"O;J\1\6?\ (UZE_P!=C_(4T!C5ZA\,O^0+>?\
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MFGN2/^>4>!_X]BL:X^*':WTO_@4DW] /ZT >B45Y9)\3-68GR[6R0>ZL2/\
MQZH?^%CZY_<M/^_9_P :=@/6:*\KB^)>KJ1YEM9N/96!_P#0JU+3XGQ$@7FF
MNH[M#(&_0X_G2L!Z!16-IOBK1M5*I;WB+*W BE^1L^@SU_#-;- !1110 45#
M<75O:1^9<SQ0I_>D<*/UK O/'F@6F0MR]PP_AAC)_4X'ZT =+17 7'Q/A!Q;
M:9(X]9)0OZ '^=9LGQ-U0G]U96:C_:#-_446 ]1HKR<_$?7,_<M/^_9_QIT?
MQ)UI3\T-DX]XV'\FIV ]6HKSFV^)\@(%UIBL.[12X_0@_P ZZ'3O'6AWY"-<
M-:R'^&X&T?\ ?73]:0'2T4B.LB!T8,I&00<@TM !1110 4444 %%%4M5U2WT
M;3WO;H.8D(!V#)Y.* +M%<C_ ,+'T/\ N7?_ '['^-.B^(>BS3)$J7>YV"C,
M8ZG\: .LHHHH **** "BBB@ HHHH ***9+(L,+RMG:BECCT% #Z*Y'_A8^A_
MW+O_ +]C_&C_ (6/H?\ <N_^_8_QH ZZBH+*[CO[*&[AW>7,@==PP<'UJ>@
MHHHH **** "BBJ5[J^G:=G[7>P0D?PNXW?EUH NT5R=U\1-#MR1$;BY/_3./
M _\ 'L5D3_% <BWTOZ-)-_0#^M 'H=%>6R?$S52?W=G9J/\ :5C_ .S"H/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !4%W+Y4!P?F;@5/65?2^9/M'1./QK@S+$>PP[:W>B_KT+A&[*U%%%?'
M'236L?F7*#L#DUL5GZ<G+O\ @*T*^KR>ER8?F_F?_ .>J[R"BBBO5,PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6HR8C
M6,=2<GZ5=KGM6O?*BFN,]!A/KVKR\WQ'LL/RK>6GRZFM&#G-)',ZY=_:+TQ*
M?DB^7\>]9E*2222<D]325\@?54X*$5%= HHHI%A1110 4444 %%%% !1110
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M_"JU%;/A72_[7\16MNRYB5O,E]-J\\_7@?C5"/4_">E_V3X<M8&7$KCS9?\
M>;G]!@?A6W114C"N%^)6F>=I]OJ2+\T#>7(1_=;I^1_]"KNJJZE8QZEIMS92
M?=FC*9]#V/X'F@#P*NC\$:I_9GB2$.V(;G]R^>G/0_GC\S6!/#);W$D$J[9(
MV*,/0@X-,!*D$$@CD$50CZ&HK,\/:F-8T*UO,Y=DVR>SC@_KS^-:=2,****
M"BBB@ JM?WD>GZ?<7DOW(8RY'K@=*LUQOQ'O_L^@Q6BMAKJ4 CU5>3^NV@#R
M^YN)+NZEN)FW22N78^I)S45%6=/LWU#4;>SC^_-($!],GK^%4(])^'6BBTTQ
M]3E7]]<_+'GM&#_4_P A7:U';P1VUO%!$NV.) BCT &!4E2,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ'Q9_P C7J7_
M %V/\A7MU>(^+/\ D:]2_P"NQ_D*: QJ]0^&7_(%O/\ KX_]E%>7UZA\,O\
MD"WG_7Q_[**&([>BBBD,*9--%;Q-+-(D<:C+.YP /<T^N=\=?\B;?_\ ;/\
M]&+0!G:M\1=.M"T=A&UY(/XONH/QZG\OQKC-2\:ZWJ1(-T;>,_P6_P GZ]?U
MKGJ*8A69G8LS%F/)).2:2E +$!023T K5M?#&MWH!ATRXP>A==@/XMBF!DT5
MUD'P[UV7[XMH?^NDN?\ T$&KJ?#'4"/GO[53_LAC_04@.&HKN_\ A6-[_P!!
M&W_[X-5I_AMK$8S%/:2CT#L#^HQ^M '&T5J:AX<UC2U+7=A*B#JZC<H_$9 K
M+I@=+H/C74=&98I7-U:#@QR'E1_LGM].E=K=_$/1H+1)8/.N)77/E*NTK[,3
MP/PS7DM%*P'6:E\0=8O25MBEG$>T8RW_ 'T?Z8KF)[B>ZE,MQ-)+(>K2,6)_
M$U%13 **LVNG7M\<6EI//_USC+8_*MJW\"^(+CDV8B7UED4?IG- '.45VL7P
MSU5L&6[LT^C,Q_E4W_"L;W_H(V__ 'P:0'"45VTOPSU-1F*\M']FW+_0UCWW
M@W7; %GL6E0?Q0D/^@Y_2@#!K6T;Q'J6AR@VDY,6<M"_*-^';ZBLH@JQ5@00
M<$'M24P/:O#OBBS\008C_=72C,D#'D>X]16[7S]:W4]E=1W-M*T<T9RK+VKV
MCPUKT7B#2EN  LZ?+-&/X6]O8TAFS1112 **** (YIXK:)I9Y4BC7EG=@ /Q
M-<AJWQ%TZT+1V$;7D@_C^Z@_$\G\OQJ[X^_Y%&Y_WX__ $(5X]30'0:EXTUO
M4LJ;HV\9_P"6=O\ (/SZ_K6 S,[%F8LQY))R324JJSL%4$L>@ ZTQ"45K6OA
MC6[T PZ9<8/0NNP'\6Q6M!\.]=E WBVA_P"NDN?_ $$&@#DZ*[E/ACJ!'SW]
MJI_V0Q_H*=_PK&]_Z"-O_P!\&E<#A**[*?X;:Q&,Q36DOL'(/ZC'ZU@ZAX<U
M?2U+7=A*D8ZR*-RC\1D4P,NNFT'QMJ6D,L4[M=V@X,<A^91_LM_3I7,T4 >M
M7?Q#T6"U22#SKB5UR(@NW;[,3P/PS7(:G\0-8OMRV[)9Q'M$,M_WT?Z8KE**
M5@))[B:YD,EQ-)+(>K2,6/YFHZ*LVNG7M\<6EI//_P!<XRW\J8%:BNDMO GB
M"XP39K"I[RR*/TSFM&+X9ZJV#+=V:?1F8_RI <517=_\*QO?^@C;_P#?!J*7
MX9ZFHS%>6C^S;E_H:+@<316[?>#M=L 6>Q>5!_%"0_Z#G]*PR"I((((X(-,#
M5T;Q'J6AR@VDY,6<M"_*-^';ZBO5?#OBBS\00?N_W5T@S) QY'N/45XI4UI=
MSV-W'=6TACFC;<K#M2 ^@:*Q_#>O1>(-*6Y4!)D^2:,?PM[>Q[5L4AA1110
M5S/C[_D4;G_?C_\ 0A735S/C[_D4;G_?C_\ 0A0!X]5C3_\ D)6O_79/YBJ]
M6-/_ .0E:_\ 79/YBJ$>_P!%%%2,**** "BBB@ HHHH *KZA_P @VZ_ZXO\
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M>Y/N3S5RO>ITU!'QN88V6+J\WV5LOZZL****T. **** "BBB@ HHHH ****
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M_D*]NKQ'Q9_R->I?]=C_ "%- 8U>H?#+_D"WG_7Q_P"RBO+Z]0^&7_(%O/\
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M[3^"/HOR1R/<****L04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>(^+/^1KU+_KL?Y"O;J\1\6?\ (UZE_P!=C_(4T!C5ZA\,O^0+>?\
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MF*KU8T__ )"5K_UV3^8JA'O]%%%2,**** "BBB@ HHHH *KZA_R#;K_KB_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI:*QO$GB"/P[IRW+0^<[N$2/?MSW)S@]*D9LT5YY_P +2_Z@W_DU_P#84?\
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MDE%%%>X8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(S*BEF.
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M%%>J?+!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%8/C'6!HGAF[N%;;-(ODPXZ[VXR/H,G\*3=E=FE*G*K-0CNW8\<\7
M:H-7\47UTK;HM_EQ^FU>!CZXS^-8E%%>8W=W/T.G35."A'9*PJJSNJ(I9F.
M .2:^@O"NBC0/#UM9$#SL;YB.[GK^7 _"O,OAKH!U+7/[1F3-M9$,,]&D_A'
MX=?RKV:NO#PLN9GS.>XOFDL/'IJ_7H%%%%=)\\%%%% !1110 4444 %%%% &
M3XEU3^Q] NKH-B7;LB_WSP/RZ_A7AW4Y-=W\2M4\V^M],1OE@'F2#_:/0?@/
M_0JX2FA"JI9@J@DDX '>O==!TT:1HEI98&Z-,O[N>6_4FO+/ ^E_VEXEA9US
M%;?OG_#[H_/'Y&O9*&,*\F^(6J?;=?%HC9BM%V>V\\M_0?A7K#;MC;,%L<9Z
M9KS.?X<:M<3R3RW]HTDC%V/S<DG)[4(#A:*[?_A66I_\_MI_X]_A1_PK+4_^
M?VT_\>_PHN(XBBNW_P"%9:G_ ,_MI_X]_A1_PK+4_P#G]M/_ ![_  HN!Q%%
M=O\ \*RU/_G]M/\ Q[_"C_A66I_\_MI_X]_A1<#B**[?_A66I_\ /[:?^/?X
M5R%_92Z=?SV<P'F0N4;'0X[CVI@3:/J#:5J]K?+G]U("P'=>A'Y$U[O'(DL:
M21L&1P&4CN#7SU7KO@#5/M_AY;=VS+9GRS_N]5/\Q^%)@=51112&%>5?$BU,
M/B"*X ^6> <_[2D@_IBO5:XOXDV'GZ)!>*,M;2X/LK<?S"T(#RRNR^&]X(/$
M$MLQP+B$@#U9>?Y;JXVKFDWS:9JUK>KG]S(&('<=Q^(R*H1[W138Y$EC22-@
MR. RD=P:=4C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *\1\6?\C7J7_78_P A7MU>(^+/^1KU+_KL?Y"F@,:O4/AE_P @
M6\_Z^/\ V45Y?7J'PR_Y MY_U\?^RBAB.WHHHI#"N=\=?\B;?_\ ;/\ ]&+7
M15SOCK_D3;__ +9_^C%H \:JQI__ "$K7_KLG\Q5>K&G_P#(2M?^NR?S%4(]
M_HHHJ1A1110 4444 %%%% $=Q_Q[2_[A_E7SY7T'<?\ 'M+_ +A_E7SY30@K
MV[PE_P BIIO_ %Q'\S7B->W>$O\ D5--_P"N(_F:&!LT444AA1110 4444 %
M%%% 'B/BS_D:]2_Z['^0K&K9\6?\C7J7_78_R%8U4(]0^&7_ "!;S_KX_P#9
M17;UQ'PR_P"0+>?]?'_LHKMZD84444 <SX^_Y%&Y_P!^/_T(5X]7L/C[_D4;
MG_?C_P#0A7CU-"+&G_\ (2M?^NR?S%>_UX!I_P#R$K7_ *[)_,5[_0QA1112
M **** "BBB@ J.X_X]I?]P_RJ2H[C_CVE_W#_*@#Y\HHHJA'N7AG_D6-,_Z]
MT_E6K65X9_Y%C3/^O=/Y5JU(PHHHH **** "BBB@ KQ'Q9_R->I?]=C_ "%>
MW5XCXL_Y&O4O^NQ_D*: QJ]0^&7_ "!;S_KX_P#917E]>H?#+_D"WG_7Q_[*
M*&([>BBBD,*YGQ]_R*-S_OQ_^A"NFKF?'W_(HW/^_'_Z$* /'JL:?_R$K7_K
MLG\Q5>K&G_\ (2M?^NR?S%4(]_HHHJ1A1110 4444 %%%% !5?4/^0;=?]<7
M_D:L57U#_D&W7_7%_P"1H \ HHHJA'N7AG_D6-,_Z]T_E6K65X9_Y%C3/^O=
M/Y5JU(PHHHH \W^*'_'SIO\ N2?S6N KO_BA_P ?.F_[DG\UK@*:$=5\/?\
MD:X_^N+_ ,J]=KR+X>_\C7'_ -<7_E7KM#&%%%%( HHHH **** "BBB@#ROX
ME_\ (QV__7HO_H;UQE=G\2_^1CM_^O1?_0WKC*8CM_AE_P AN[_Z]O\ V85Z
MA7E_PR_Y#=W_ ->W_LPKU"AC"BBBD!YO\4/^/G3?]R3^:UP%>B?%%/\ D%R
M?\]03_WSC^M>=TT(**NZ5I=QK&H)96Q02N"1O.!P,UT/_"N-<_OVG_?P_P"%
M,#D:*Z[_ (5QKG]^T_[^'_"C_A7&N?W[3_OX?\*0'(T5UW_"N-<_OVG_ '\/
M^%'_  KC7/[]I_W\/^% '(T5UW_"N-<_OVG_ '\/^%'_  KC7/[]I_W\/^%
M'(T5UW_"N-<_OVG_ '\/^%'_  KC7/[]I_W\/^% '(T5UW_"N-<_OVG_ '\/
M^%'_  KC7/[]I_W\/^% '(UV?PT_Y&.X_P"O1O\ T-*B_P"%<:Y_?M/^_A_P
MKH_!OA/4-!U6:ZO&A*O 8U\MR>2P/I[4 =M1112&%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXTF?'^S_ .A"K]9^MY_LJ7ZK_,4,UH?Q8^J.3HHHK,^A"BBB@ HHHH ****
M"BBB@ K!\17VV,6<9Y;YG]AV%:]Y=)9VKSOT4<#U/85Q$TSW$SRR'+N<FO2R
M[#\\_:2V7YG3AJ?,^9]#8\&V7V_Q?ID)&5$PD/T0;OZ5] 5XY\*[82^*)IB.
M(;9B#[D@?RS7L=?5X=6C<^?SZIS8E1[+\]0HHHK<\0**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ[XGZW]NUI-,B;,-D/
MGP>#(>OY# _.O2O$NMQZ!H5Q?,1Y@&V%3_$YZ#^OT!KY]FEDGFDFE<O)(Q9V
M/4DG)-<V(G9<J/H,BPG--XB6RT7K_P #]1E2V]O+=W,5O A>65@B*.I). *B
MKTSX8>&MS-KUTG REJ"._1G_ *#\:YH0<Y6/H,9B8X:BZDOEYL[OPYHL6@:)
M;V$>"RC=*X_C<]3_ $'L!6K117HI65D? SG*I)SENPHHHIDA1110 4444 %%
M%% !4=Q/':VTMQ,VV.)"['T &34E<?\ $35/L>AK9(V);ML'']Q>3^N!^= '
MF.HWLFHZC<7DOWYI"Y'IZ#\!Q5:BK.GV<FHZA;V<7WYI @/ID]?PZU0CT[X=
MZ7]CT)KQUQ)=MN&?[@X']3^-=A4=O!':VT5O"NV.) BCT &!4E2,**** "BB
MB@ HHHH **** "O,?B3I?DZE!J2+\MPNR0_[2]/S'\J].K%\5Z7_ &MX<NH%
M7,J+YL7KN7G ^HR/QH \2KI_ >J?V=XCCB=L178\EL_WOX3^?'XUS%*CM&ZN
MC%64Y!'4&J$?0U%9^AZDNKZ-:WJXS(GS@=F'##\P:T*D854U.Q34M,N;)^!-
M&4SZ'L?P/-6Z* /GN:%[>>2&52LD;%&4]B#@BF5VGQ$T8V>JKJ42_N;KA\#@
M2 ?U'/YUQ=4(]9^'^LB_T7[#(V9[/"C/>,_=_+I^ KKJ\)T/5YM#U:*]BY"_
M+(G]]#U'^>^*]OL[N"_LXKJV</#*NY6%)C)Z***0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5XCXL_Y&O4O^NQ_D*]NKQ'Q9_R
M->I?]=C_ "%- 8U>H?#+_D"WG_7Q_P"RBO+Z]0^&7_(%O/\ KX_]E%#$=O11
M12&%<[XZ_P"1-O\ _MG_ .C%KHJYWQU_R)M__P!L_P#T8M 'C56-/_Y"5K_U
MV3^8JO5C3_\ D)6O_79/YBJ$>_T445(PHHHH **** "BBB@".X_X]I?]P_RK
MY\KZ#N/^/:7_ '#_ "KY\IH05[=X2_Y%33?^N(_F:\1KV[PE_P BIIO_ %Q'
M\S0P-FBBBD,**** "BBB@ HHHH \1\6?\C7J7_78_P A6-6SXL_Y&O4O^NQ_
MD*QJH1ZA\,O^0+>?]?'_ +**[>N(^&7_ "!;S_KX_P#917;U(PHHHH YGQ]_
MR*-S_OQ_^A"O'J]A\??\BC<_[\?_ *$*\>IH18T__D)6O_79/YBO?Z\ T_\
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MWL6::[J@RS #WK.DU"1N$ 0?F:JL[.<LQ)]Z\NOG5*.E)7?W+_,T5)]2_+J
M'$2Y/J:HO(\C;G8DTVBO#Q&,K8A^^].W0VC%1V"BBBN484444 %%%% !5'61
MG29_P_\ 0A5ZJNI+OTVX'^P3^7-!I2=JD7YHXVBBBLSZ(**** "BBB@ HHHH
M ***Q=>U+[/%]EB;]ZX^8C^%?_KUK1I2JS4(E0@YRLC+UO4?MESY<9_<QG _
MVCZUET45]/2IQIP4([(]2,5%61Z5\(H@;C5I>,JL2_F6_P *]2KS3X1;?)U;
M&-^Z+/TP^/ZUZ77IT/@1\5G#OC)_+\D%%%%:GF!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 445Q/Q$\4#2--_LZUDQ>W2X)'6./
MH3]3T'XU,I**NS;#T)XBJJ<-V<1\0/$G]MZT;:W?-E:$HA!X=_XF_H/I[UR%
M%2002W5Q'!!&TDLC!411RQ/05YTI.3NS[ZA1AAZ2IQV7]7-;POX?E\1ZU%9I
MN6%?GGD'\"#K^)Z"O?;>WBM+:*W@01Q1*$11T '2L7PCX;C\-Z.L!PUU+A[B
M0=V]![#_ !/>M^NZC3Y%KN?'YICOK56T?A6W^?\ 70****U/+"BBB@ HHHH
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MX9?\@6\_Z^/_ &45Y?7J'PR_Y MY_P!?'_LHH8CMZ***0PI" 001D'J#2T4
M>":K9'3M6N[,@_N9649[C/!_+%4Z[SXDZ08KR#58U^24>7*0.C#H?Q''_ :X
M.J$>L_#S4Q>>'_LC-^]M'*XSSM/(/\Q^%==7A_AO7'T'5X[H M"WR3(/XE/]
M1UKVNVN8;RVCN+>19(I%W*R]"*3&2T444@"BBB@ HHHH *X#XF:F%M[73$/S
M.WG2#T X7\SG\J[34M2MM)L)+RZ?;&@Z=V/8#W->(:MJ<VKZG/?3_?E;A1T4
M=@/H*: I5N>#['[?XHLD(RD;^<WT7G^>!^-8=>F_#;2#!93ZI*I#3GRXLC^
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M.HH&M#@R,'!HJSJ$7DZA.G^V2/H>:K5!]'&7,DPHHHI%!1110 445%<7$=K
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M&GADMKB2"5=LD;%&'H0<&OH.O)OB'I?V+7Q=HN(KM=WMO'#?T/XTT!R->O\
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MBBB@ HHHH **** "BBB@ KQ'Q9_R->I?]=C_ "%>W5XCXL_Y&O4O^NQ_D*:
MQJ]0^&7_ "!;S_KX_P#917E]>H?#+_D"WG_7Q_[**&([>BBBD,*YWQU_R)M_
M_P!L_P#T8M=%7.^.O^1-O_\ MG_Z,6@#QJK&G_\ (2M?^NR?S%5ZL:?_ ,A*
MU_Z[)_,50CW^BBBI&%%%% !1110 4444 1W'_'M+_N'^5?/E?0=Q_P >TO\
MN'^5?/E-""O;O"7_ "*FF_\ 7$?S->(U[=X2_P"14TW_ *XC^9H8&S1112&%
M%%% !1110 4444 >(^+/^1KU+_KL?Y"L:MGQ9_R->I?]=C_(5C50CU#X9?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3H,]UK@OL\W_ #QD_P"^37T'13N!Y+\/XI$\4H6C=1Y3\D8[5ZU112 ****
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MQJW112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#^H_ESZUW=>C&2DKH^!Q.'GAZCISW7]7"BBBJ, HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[3+S5KQ+2QMWFF;LHX ]2>@'N:YFW)ZGT5.E2P\+02C%%0 D@ 9)[5Z1X/\
MATT_EZAKD96+[T=H>"WN_H/;\ZZ/PIX!L]""7=YLNM0ZAL?)%_N@]_?^5=C7
M52H6UD?.YAG+E>GA]N_^7^8U$6-%1%"HHPJJ, #T%.HHKI/G0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** &R(LB%&&0:R)X&@?!Z'H?6MFF21K*A1QD?RKS\?@8XJ-UI);?Y,N$
M^4Q**FGMW@;!Y4]&J&ODJE.5.3A-6:.E.^J"BBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***4 DX R?04 )3XXGE;:BDFK4%@S?-
M*=H]!UJ^D:QKM10!7KX3*:E7WJONK\?^ 9RJ);%>WLDBPS_,_P"@JU117TE&
MA3HQY*:LC!MO<*XGQWX,&N0'4+! -1C7YE''G*.W^\.WY>E=M15RBI*S-</B
M)X>HJE-ZH^971HW9'4JZG#*PP0?0TVO9/&W@5-;#:AIJK'J 'SIT$_\ @WO^
M?K7CTT,MO,\,T;1RH=K(PP0?0BN"I3<'9GV^"QM/%PYH[]5V_P" ,HHHJ#M"
MBBB@ HHHH **** "BBB@ J>TO;JPG$]I<2P2CH\;%3^E044":35F=SIGQ1UB
MT"I?10WJ#N1Y;_F./TKJK/XIZ). +F&ZMF[Y0.OY@Y_2O'**UC6FNIYM;*,)
M5UY;/RT_X![[!XV\-W ^35X!_P!=,I_Z$!5L>)=!(!&M:=SZW2#^M?.]%7]9
MEV.-\/T>DW^!]#OXGT%!DZUIY_W;A#_(U1G\>>&;<?-JB.?2-&;^0KP:BAXF
M78<>'Z"WFW]Q[!=_%71H<BVM;NX;L2 BG\2<_I7.7_Q5U>XRME:V]HIZ$YD8
M?B<#]*X*BH=:;ZG72RC"4]>6_KJ:&HZ[JFKMF_OYYQ_<9L*/HHX'Y5GT45DV
MWN>C&$8*T59!16IHOAW4]?G\NPMF=0<-*W")]3_3K7JOASX=Z;HY2XO<7MX.
M07'[M#[+W^I_2M(4I3V.+%YC0PJM)WEV6_\ P#A/#/@'4==*7%R&M+ \^8P^
M:0?[(_J>/K7KVCZ)I^A6@MK"W6-?XFZLY]6/>M"BNR%*,-CY/&9C6Q3M)VCV
M7]:A1116AP!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVEMY1_#(I&?<>H]ZK5SGN*2DKIZ!1110,**** "BBB@ HHHH **** "BBB@
MHHI55G8*H)8G  &2: $HKJ-)^'^OZIM8VOV2$_QW/R_^.]?TKOM&^&>CZ>5D
MOF:_F'9QMC!_W1U_$FM(T9R/.Q&:8:AHY7?9:_\  /*])T'4];E\O3[228 X
M9\81?JQX%>D:#\+K.UVS:Q-]JE'/DQDK&/J>K?I7?Q0Q6\2Q0QI'&@PJ(H
M]@*?73"A&.^I\_BLZKUO=I^ZOQ^__(C@@AMH4A@B2*)!A410 ![ 5)116YXS
M=]6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
